Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report

Cemiplimab is a novel programmed death-1 inhibitor recently approved for advanced cutaneous squamous cell carcinoma. Immune-related adverse events derived from cemiplimab are similar to other anti-PD-1 drugs, including gastrointestinal and cutaneous toxicities. Oral immune-related adverse events wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Mariana Henriques, Bezinelli, Letícia Mello, Eduardo, Fernanda de Paula, Gobbi, Marcella Ferreira, Corrêa, Luciana, Schvartsman, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868819/
https://www.ncbi.nlm.nih.gov/pubmed/35303053
http://dx.doi.org/10.31744/einstein_journal/2022RC6367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868819/
https://www.ncbi.nlm.nih.gov/pubmed/35303053
http://dx.doi.org/10.31744/einstein_journal/2022RC6367

Ejemplares similares